S. Mento

发表

Oral poliovirus vaccine in the United States: Molecular characterization of sabin type 3 after replication in the gut of vaccinees

C. Weeks-Levy, J. Tatem, S. Mento, 1991, Journal of medical virology.

Identification and characterization of a new base substitution in the vaccine strain of Sabin 3 poliovirus.

C. Weeks-Levy, J. Tatem, S. Mento, 1991, Virology.

A mutation present in the amino terminus of Sabin 3 poliovirus VP1 protein is attenuating

G. Schild, M. Skinner, G. Dunn, 1992, Journal of virology.

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer

S. Chang, T. Banks, T. Dubensky, 1996, Journal of virology.

Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens

S. Chang, T. Banks, D. Driver, 1997, Journal of virology.

Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.

A. Abramovitz, S. Mento, E. Mishkin, 1991, Vaccine.

Isolation and preliminary characterization of Sindbis virus-resistant Chinese hamster ovary cells.

L. Siminovitch, S. Mento, 1981, Virology.

Generation of a systemic antitumor response with regional intratumoral injections of interferon gamma retroviral vector.

S. Mento, J. Robbins, D. Jolly, 1998, Human gene therapy.

Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen.

S. Mento, M. Sällberg, W. Lee, 1998, Human gene therapy.

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.

T. Dubensky, D. Driver, B. Belli, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Characterization of Vero cells.

C. Weeks-Levy, S. Mento, M. Ritchey, 1988, Journal of biological standardization.

Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors.

J. Murphy, S. Mento, W. Manning, 1998, Journal of virological methods.

Layered Amplification of Gene Expression with a DNA Gene Delivery System

T. Banks, T. Dubensky, S. Chada, 1995, Annals of the New York Academy of Sciences.

Sabin inactivated trivalent poliovirus vaccine: first clinical trial and seroimmunity survey

C. Grose, S. Mento, M. Ritchey, 1988, The Pediatric infectious disease journal.

Phenotypic characterization of ouabain‐resistant Aedes albopictus cells

V. Stollar, S. Mento, F. Malinoski, 1979, Journal of cellular physiology.

Isolation and partial characterization of drug-resistantAedes albopictus cells

V. Stollar, S. Mento, 1978 .

α-Amanitin resistant RNA polymerase II from Aedes albopictus cell mutants resistant to α-amanitin

V. Stollar, S. Mento, 1979 .

Effect of ouabain on sindbis virus replication in ouabain-sensitive and ouabain-resistant Aedes albopictus cells (Singh).

V. Stollar, S. Mento, 1978, Virology.

Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.

D. Martineau, S. Mento, W. Klump, 1997, Human gene therapy.

Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays.

S. Mento, D. Jolly, M. Printz, 1995, Gene therapy.

Cytotoxic T‐lymphocyte induction in asymptomatic HIV‐1‐infected patients immunized with Retrovector®‐transduced autologous fibroblasts expressing HIV‐1IIIB Env/Rev proteins

S. Mento, W. Klump, D. Jolly, 1995, AIDS.

Retroviral Vectors for HIV Immunotherapy

R. Haubrich, S. Mento, J. Warner, 1995, Annals of the New York Academy of Sciences.

On the regulation of cyclic AMP level in bacteria. II. In vitro regulation of adenylate cyclase activity. Solubilization and reconstitution of a functional membrane-bound adenylate cyclase system responsive to regulation by glucose.

S. Mento, M. Abou-Sabé, 1975, Biochimica et biophysica acta.

Viruses may be etiologic agents for non-insulin-dependent (type II) diabetes.

E. Rayfield, S. Mento, 1983, Reviews of infectious diseases.

Evidence for localization of biologically active recombinant retroviral vector to lymph nodes in mice injected intramuscularly.

S. Chada, S. Mento, W. Edwards, 1996, Gene therapy.

Recombinant retroviral vector delivered intramuscularly localizes to the site of injection in mice.

S. Chada, S. Mento, D. Jolly, 1994, Human gene therapy.

An oral caspase inhibitor as monotherapy or with antibiotics eradicates MRSA skin infections in mice.

M. Alphonse, S. Mento, L. Miller, 2023, Drug development research.